Is a complete LON/HLN research report available?

Question

Accepted Answer

No complete published report is available for lon/HLN (LON/HLN) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

Market cap	33.6B
Revenue (ttm)	11B
Net income (ttm)	1.7B
EPS (ttm)	GBX 0.19
Shares out	8.8B
P/E (trailing)	20.6x
P/E (forward)	18.4x
Dividend	GBX 0.07 (1.92%)
Volume	29,790,889

Metric	Value
Country	United Kingdom
Country code	UK
Employees	24,535
Employees Change	-26%
Employees Change Percent	-0.11
Enterprise value	GBX 40.9B
Exchange	London Stock Exchange
Financial currency	GBP
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Industry PE	16.71
Industry PE Fwd	17.01
Isin	GB00BMX86B70
Last refreshed	2026-07-29
Market cap	GBX 33.6B
Price	GBX 381
Price currency	GBX
Rev Per Employee	449,561.85x
Sector	Healthcare
Sector PE	20.72
Sector PE Fwd	14.39
Sic	2834
Symbol	lon/HLN
Website	https://www.haleon.com

Metric	Value
Earnings Yield	4.97%
EV Earnings	24.53x
EV/EBIT	16.34x
EV/EBITDA	14.64x
EV/FCF	17.69x
EV/Sales	3.71x
FCF yield	6.89%
Forward P/E	18.42x
P/B ratio	2.04x
P/E ratio	20.59x
P/S ratio	3.04x
PE Ratio3 Y	25.03x
PE Ratio5 Y	24.81x
PEG ratio	2.5x

Metric	Value
EBIT Margin	22.69%
EBITDA Margin	24.87%
FCF margin	20.96%
Gross margin	64.77%
Gross Profit	GBX 7.1B
Gross Profit Growth	0.58%
Gross Profit Growth Q	-0.14%
Gross Profit Growth3 Y	2.01%
Net Income	GBX 1.7B
Net Income Growth	15.6%
Net Income Growth Q	86.36%
Net Income Growth Quarters	1%
Net Income Growth Years	2%
Net Income Growth3 Y	16.29%
Pretax Margin	19.51%
Profit Margin	15.11%
Profit Per Employee	GBX 67,944
Profitable Quarters	GBX 8
Profitable Years	7
ROA	4.67
Roa5y	4.32
ROCE	9.04
ROE	10.27
Roe5y	7.32
ROIC	8.22
Roic5y	7.01

Metric	Value
Cagr1y	6.27%
Cagr3y	6.08%
EPS Growth	17.83
EPS Growth Q	92.03
EPS Growth Quarters	1
EPS Growth Years	2
EPS Growth3 Y	17.25
FCF Growth	12.73%
FCF Growth3 Y	9.54%
OCF Growth	14.47%
OCF Growth3 Y	8.49%
Revenue Growth	-1.81x
Revenue Growth Q	0.58x
Revenue Growth Quarters	1x
Revenue Growth Years	0x
Revenue Growth3 Y	0.53x

LON/HLN (LON/HLN)

Coverage state: Market snapshot only — no published research

Generate the first LON/HLN analysis

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · LON/HLN

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All LON/HLN indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on LON/HLN

Frequently asked questions

Metric	Value
Asset Turnover	GBX 0.33
Assets	GBX 32.6B
Cash	GBX 1.4B
Current Assets	GBX 4.6B
Current Liabilities	GBX 4.9B
Debt	GBX 8.6B
Debt EBITDA	GBX 3.09
Debt Equity	GBX 0.52
Debt FCF	GBX 3.73
Equity	GBX 16.5B
Interest Coverage	7.21
Liabilities	GBX 16.1B
Long Term Assets	GBX 28.1B
Long Term Liabilities	GBX 11.2B
Net Cash	GBX -7.3B
Net Cash By Market Cap	GBX -21.71
Net Debt EBITDA	GBX 2.66
Net Debt Equity	GBX 0.44
Net Debt FCF	GBX 3.15
Tangible Book Value	GBX -9.2B
Tangible Book Value Per Share	GBX -1.03
WACC	5.08

Metric	Value
Current ratio	0.92
Inventory Turnover	3.51
Net Working Capital	GBX -896M
Quick ratio	0.68
Working Capital	GBX -383M
Working Capital Turnover	GBX -46.25

Metric	Value
Buyback Yield	1.62%
Dividend Growth	7.58%
Dividend Growth Years	2%
Dividend per share	GBX 0.07
Dividend Years	4
Dividend Yield	1.92%
Ex Div Date	2026-04-09
Last Dividend	GBX 0.05
Payout Frequency	Semi-Annual
Payout Ratio	36.71%

Metric	Value
1Y total return	6.27%
200-day SMA	362.9
3Y total return	19.37%
50-day SMA	348.4
50-day SMA vs 200-day SMA	50under200
All Time High	419.5
All Time High Change	-9.2%
All Time High Date	2025-05-30
All Time Low	241.2
All Time Low Change	57.92%
All Time Low Date	2022-09-05
ATR	7.82
Beta	0.24
Beta1y	0.16
Beta2y	0.16
Ch YTD	1.63
High	384.2
High52	416.1
High52 Date	2026-02-18
High52ch	-8.46%
Low	372.6
Low52	274.4
Low52 Date	2025-09-22
Low52ch	38.81%
Ma50ch	9.34%
Price vs 200-day SMA	4.95%
RSI	68.42
RSI Monthly	54.84
RSI Weekly	59.67
Sharpe ratio	0.18x
Sortino ratio	0.52
Total Return	3.54%
Tr YTD	3
Tr1m	9.36%
Tr1w	3.34%
Tr3m	8.74%

Metric	Value
Analyst Count	18
Analyst Count Top	1
Analyst Price Target Top	GBX 370
Analyst Ratings	Buy
Analyst Ratings Top	Hold
Operating Income	GBX 2.5B
Operating Income Growth	0.64
Operating Income Growth Q	1.9
Operating Income Growth3 Y	1.47
Operating margin	22.69
Price target	GBX 414
Price Target Change	GBX 8.75
Price Target Change Top	GBX -2.86

Metric	Value
Float	8,779,024,590%
Net Borrowing	-1,366,000,000
Shares Insiders	0.07%
Shares Institutions	94.08%
Shares Out	8,808,899,708
Shares Qo Q	0%
Shares Yo Y	-1.62%

Metric	Value
Adjusted FCF	GBX 2.2B
Adjusted OCF	2,548,000,000
Average Volume	19,348,045.1x
Bv Per Share	1.84
CAPEX	GBX -322M
Ch1m	9.36
Ch1w	3.34
Ch1y	4.21
Ch3m	8.74
Ch3y	12.93
Ch6m	1.14
Change	2.89%
Change From Open	2.23
Close	370.2
Days Gap	0.65
Depreciation Amortization	240,000,000
Dollar Volume	11,347,349,620.1
Earnings Date	2026-07-30
EBIT	GBX 2.5B
EBITDA	GBX 2.7B
EPS	GBX 0.19
F Score	7
FCF	GBX 2.3B
FCF EV Yield	5.65x
FCF Per Share	GBX 0.26
Financing CF	-3,143,000,000
Fiscal Year End	December
Founded	1,715
Goodwill	8,127,000,000
Graham Number	282.273
Graham Upside	-25.89
Income Tax	GBX 472M
Investing CF	-346,000,000
Is Primary Listing	1
Last Earnings Date	2026-02-25
Last Report Date	2025-12-31
Lynch Fair Value	GBX 308
Lynch Upside	-19.07
Ma150	363.7
Ma150ch	4.74%
Ma20	364.7
Ma20ch	4.44%
Net CF	-904,000,000
Next Earnings Date	2026-07-30
Open	372.6
P FCF Ratio	14.51
P FCF Ratio SBC	15.07
P OCF Ratio	12.74
P OCF Ratio SBC	13.17
Payment Date	2026-05-14
Position In Range	71.55
Ppne	1,997,000,000
Price Date	2026-07-28
Price EBITDA	GBX 12.23
Relative Volume	1.54x
Revenue	11,030,000,000x
SBC By Revenue	0.78x
Share Based Comp	86,000,000
Tax By Revenue	4.28x
Tax Rate	21.93%
Tr6m	2.5%
Volume	29,790,889
Z Score	3.02